FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
IMMUNOHEMATOLOGY AND BLOOD TRANSFUSION
PAPER-III
IMHT/J/20/15/III
Max. Marks:100
Important Instructions:
Attempt al questions in order.
Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1.
Role of transfusion medicine specialist in ABO incompatible Kidney
Transplant.
2.
Pathophysiology, diagnosis and management of fetal and neo-natal
10
3.
a) Functions of Hospital Transfusion Committee.
5+5
b) Rational use of blood components.
a) Cryopreservation of peripheral blood stem cells.
5+5
b) Factors affecting the quality of cryopreserved stem cel s.
5.
5+5
(TRALI).
b) Strategies for prevention of TRALI.
6.
5+5
b) How wil you minimize the common side effects of massive
transfusion?
7.
5+5
b) Blood component therapy in the management of trauma induced
coagulopathy.
8.
5+5
b) Clinical significance of anti-D quantification in the management of
immunized mother.
P.T.O.
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
IMMUNOHEMATOLOGY AND BLOOD TRANSFUSION
PAPER-III
9.
a) Clinically significant red cell antibodies.
b) Cellular assays to decide hemolytic potential of red cell antibody.
10
a) Transfusion support in a case of dengue haemorrhagic syndrome.
5+5
India.
************
-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
IMMUNOHEMATOLOGY AND BLOOD TRANSFUSION
PAPER-III
--- Content provided by FirstRanker.com ---
Time: 3 hoursIMHT/J/20/15/III
Max. Marks:100
Important Instructions:
Attempt al questions in order.
--- Content provided by FirstRanker.com ---
Each question carries 10 marks.Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
--- Content provided by FirstRanker.com ---
Start the answer to a question on a fresh page or leave adequate space between two answers.Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1.
Role of transfusion medicine specialist in ABO incompatible Kidney
--- Content provided by FirstRanker.com ---
10Transplant.
2.
Pathophysiology, diagnosis and management of fetal and neo-natal
10
--- Content provided by FirstRanker.com ---
alloimmune thrombocytopenia.3.
a) Functions of Hospital Transfusion Committee.
5+5
b) Rational use of blood components.
--- Content provided by FirstRanker.com ---
4.a) Cryopreservation of peripheral blood stem cells.
5+5
b) Factors affecting the quality of cryopreserved stem cel s.
5.
--- Content provided by FirstRanker.com ---
a) Pathogenesis of Transfusion Associated Acute Lung Injury5+5
(TRALI).
b) Strategies for prevention of TRALI.
6.
--- Content provided by FirstRanker.com ---
a) Massive Transfusion Protocols.5+5
b) How wil you minimize the common side effects of massive
transfusion?
7.
--- Content provided by FirstRanker.com ---
a) Pathogenesis of trauma induced coagulopathy.5+5
b) Blood component therapy in the management of trauma induced
coagulopathy.
8.
--- Content provided by FirstRanker.com ---
a) Methods of quantification of anti-D in an immunized mother.5+5
b) Clinical significance of anti-D quantification in the management of
immunized mother.
P.T.O.
--- Content provided by FirstRanker.com ---
-1-POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
--- Content provided by FirstRanker.com ---
JUNE 2020IMMUNOHEMATOLOGY AND BLOOD TRANSFUSION
PAPER-III
9.
a) Clinically significant red cell antibodies.
--- Content provided by FirstRanker.com ---
5+5b) Cellular assays to decide hemolytic potential of red cell antibody.
10
a) Transfusion support in a case of dengue haemorrhagic syndrome.
5+5
--- Content provided by FirstRanker.com ---
b) Risk mitigation strategies for transfusion transmitted dengue inIndia.
************
-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
--- Content provided by FirstRanker.com ---
EXAMINATION HALL.